After TGFβ promotes the release of linc-ROR from EVs, linc-ROR inhibits cancer cell apoptosis by regulating the p53-dependent signaling pathway, which serves as a mediator of TGFβ resistance to HCC chemotherapy [111]. The gene discussed is TGFB1; the disease is cancer.